Updates
Cocaine Overdose Deaths Skyrocketing
A new government report shows cocaine overdose deaths in the United States have nearly tripled over the past five years. After a period of stability, cocaine-induced deaths rose by about 27% per year, on average, from 2013 through 2018, according to researchers at the...
Study Suggests Differences by Sex and Gender in Current Opioid Epidemic
The opioid epidemic continues to evolve and impact all groups of people. Moreover, there are concerning trends among women. The aim of the linked article is to provide a review of opioid use disorder in women and the implications for treatment. Read the full study:...
Addressing Opioid Overdose Deaths: The Vision for the HEALing Communities Study
As the U.S. faces the opioid epidemic and the COVID-19 pandemic, one of the most ambitious implementation studies in addiction research is moving forward. The National Institutes of Health (NIH) and the Substance Abuse and Mental Health Services Administration...
4-Year Extension of Practice Pathway for Addiction Medicine
The American Board of Preventive Medicine (ABPM) and the American Society of Addiction Medicine (ASAM) have announced the American Board of Medical Specialties’ (ABMS) approval of a four-year extension of the practice pathway in Addiction Medicine. The extension will...
New Research Suggests Lowering Nicotine Reduces Smoking Addictiveness in Vulnerable Populations
Cigarette smoking is attributed to more than 480,000 U.S. deaths per year, as well as diseases affecting 16 million Americans, according to the Centers for Disease Control and Prevention. This behavior continues to be overrepresented among those with mental illness,...
New Research Identifies Motivation for Prescription Stimulant Misuse by Age Group
A new study published in the Journal of Clinical Psychiatry shows that abuse of prescription stimulant medication by adolescents and young adults is driven by different motivations linked to age. "We're interested in the reasons why adolescents and young adults misuse...
Target Audience
Sessions 1-3: Physicians, nurse practitioners or other advanced practice nurses, PAs, psychologists, social workers, clinical administrators and healthcare teams.
Sessions 4-6: Physicians, nurse practitioners or other advanced practice nurses, PAs, and healthcare teams.
Date: Monday, January 25, 2021
Time: 5:00 pm – 9:30 pm PT
What: Live portion of 8-hour MAT waiver course
Sponsoring organization: American Osteopathic Academy of Addiction Medicine (AOAAM)
Course Director: William Morrone, DO
How it Works: When you have completed the entire course, you will receive a certificate of completion. Physicians will then be able to apply for the waiver to prescribe buprenorphine. All other eligible providers can apply for the waiver after completing an additional 16-hour course here for advanced practice nurses and here for PAs.
Target Audience
Sessions 1-3: Physicians, nurse practitioners or other advanced practice nurses, PAs, psychologists, social workers, clinical administrators and healthcare teams.
Sessions 4-6: Physicians, nurse practitioners or other advanced practice nurses, PAs, and healthcare teams.
Learn more about our conferences and educational opportunities
Addiction Medicine Spring and Fall Conferences provide up-to-date substance use related education, applicable across general medical as well as addiction specialty practices.